This webinar will bring together four world-class experts in the field of diabetes care, who will discuss the AT278 clinical data as well as the clinical and patient need.
Moderated by: Jay Skyler, Professor of Medicine, Pediatrics & Psychology, in the Division of Endocrinology Diabetes & Metabolism at the University of Miami, USA.
Speakers and session titles:
Wendy Lane: The increased need for rapid-acting concentrated insulin products for people living with type 2 diabetes from a clinical perspective
Davida Kruger: The benefits of concentrated insulin from the patient perspective
Thomas Pieber: Summary of the results from Arecor's phase 1 clinical trial of its ultra-rapid, ultra-concentrated insulin product candidate, AT278